Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
The development of two White Plymouth Rock lines resistant to Marek's disease by breeding from survivors.

Avian pathology : journal of the W.V.P.A

Maas HJ, Antonisse HW, van der Zypp AJ, Groenendal JE, Kok GL.
PMID: 18770133
Avian Pathol. 1981 Apr;10(2):137-50. doi: 10.1080/03079458108418468.

A programme to develop resistance to Marek's disease (MD) in chickens in two non-inbred White Plymouth Rock (WPR) lines by breeding from survivors was initiated in 1968 and since then nine generations have been produced. In each generation only...

Cite
Maas HJ, Antonisse HW, van der Zypp AJ, et al. The development of two White Plymouth Rock lines resistant to Marek's disease by breeding from survivors. Avian Pathol. 1981;10(2):137-50doi: 10.1080/03079458108418468.
Maas, H. J., Antonisse, H. W., van der Zypp, A. J., Groenendal, J. E., & Kok, G. L. (1981). The development of two White Plymouth Rock lines resistant to Marek's disease by breeding from survivors. Avian pathology : journal of the W.V.P.A, 10(2), 137-50. https://doi.org/10.1080/03079458108418468
Maas, H J, et al. "The development of two White Plymouth Rock lines resistant to Marek's disease by breeding from survivors." Avian pathology : journal of the W.V.P.A vol. 10,2 (1981): 137-50. doi: https://doi.org/10.1080/03079458108418468
Maas HJ, Antonisse HW, van der Zypp AJ, Groenendal JE, Kok GL. The development of two White Plymouth Rock lines resistant to Marek's disease by breeding from survivors. Avian Pathol. 1981 Apr;10(2):137-50. doi: 10.1080/03079458108418468. PMID: 18770133.
Copy Download .nbib Format: NLM
Pharmacoeconomics of quetiapine for the management of acute mania in bipolar I disorder.

Expert review of pharmacoeconomics & outcomes research

Klok RM, Al Hadithy AF, van Schayk NP, Antonisse AJ, Caro JJ, Brouwers JR, Postma MJ.
PMID: 20528391
Expert Rev Pharmacoecon Outcomes Res. 2007 Oct;7(5):459-67. doi: 10.1586/14737167.7.5.459.

Bipolar disorder (or manic depression) is a lifelong, severe and complex psychiatric illness characterized by recurrent episodes of depression and mania. The aim of this study is to explore the cost-effectiveness of quetiapine compared with other alternatives for the...

Cite
Klok RM, Al Hadithy AF, van Schayk NP, et al. Pharmacoeconomics of quetiapine for the management of acute mania in bipolar I disorder. Expert Rev Pharmacoecon Outcomes Res. 2007;7(5):459-67doi: 10.1586/14737167.7.5.459.
Klok, R. M., Al Hadithy, A. F., van Schayk, N. P., Antonisse, A. J., Caro, J. J., Brouwers, J. R., & Postma, M. J. (2007). Pharmacoeconomics of quetiapine for the management of acute mania in bipolar I disorder. Expert review of pharmacoeconomics & outcomes research, 7(5), 459-67. https://doi.org/10.1586/14737167.7.5.459
Klok, Rogier M, et al. "Pharmacoeconomics of quetiapine for the management of acute mania in bipolar I disorder." Expert review of pharmacoeconomics & outcomes research vol. 7,5 (2007): 459-67. doi: https://doi.org/10.1586/14737167.7.5.459
Klok RM, Al Hadithy AF, van Schayk NP, Antonisse AJ, Caro JJ, Brouwers JR, Postma MJ. Pharmacoeconomics of quetiapine for the management of acute mania in bipolar I disorder. Expert Rev Pharmacoecon Outcomes Res. 2007 Oct;7(5):459-67. doi: 10.1586/14737167.7.5.459. PMID: 20528391.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries